Cytori Therapeutics reported $9.17M in Current Assets for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Baxter International BAX:US $ 8411M 622M
Cerus CERS:US $ 183.43M 6.13M
Cytori Therapeutics CYTX:US $ 9.17M 526K
Genocea Biosciences GNCA:US $ 82.23M 8.1M
Haemonetics HAE:US $ 668.35M 91.93M
Infinity Pharmaceuticals INFI:US $ 43.48M 1.32M
Mirati Therapeutics MRTX:US $ 1403.64M 808.25M
Starpharma Holdings Ltd SPL:AU 75.7M 39.02M
Sunesis Pharmaceuticals SNSS:US $ 22.14M 5.48M
Teva Pharmaceutical TEVA:IT 13B 845M